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Abstract
Background: The prevalence of azole resistance in clinical and environmental Aspergillus fumigatus isolates is rising
over the past decades, but the molecular basis of the development of antifungal drug resistance is not well
understood. This study focuses on the role of phenotypic plasticity in the evolution of azole resistance in A.
fumigatus. When A. fumigatus is challenged with a new stressful environment, phenotypic plasticity may allow A.
fumigatus to adjust their physiology to still enable growth and reproduction, therefore allowing the establishment
of genetic adaptations through natural selection on the available variation in the mutational and recombinational
gene pool. To investigate these short-term physiological adaptations, we conducted time series transcriptome
analyses on three clinical A. fumigatus isolates, during incubation with itraconazole.
Results: After analysis of expression patterns, we identified 3955, 3430, 1207, and 1101 differentially expressed
genes (DEGs), after 30, 60, 120 and 240 min of incubation with itraconazole, respectively. We explored the general
functions in these gene groups and we identified 186 genes that were differentially expressed during the whole
time series. Additionally, we investigated expression patterns of potential novel drug-efflux transporters, genes
involved in ergosterol and phospholipid biosynthesis, and the known MAPK proteins of A. fumigatus.
Conclusions: Our data suggests that A. fumigatus adjusts its transcriptome quickly within 60 min of exposure to
itraconazole. Further investigation of these short-term adaptive phenotypic plasticity mechanisms might enable us
to understand how the direct response of A. fumigatus to itraconazole promotes survival of the fungus in the
patient, before any “hard-wired” genetic mutations arise.
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Background
Aspergillus fumigatus is an ubiquitous fungus that plays
an important role in carbon and nitrogen recycling in
nature by degradation of organic biomass. It can be
found in many terrestrial habitats, including soil and
decaying organic matter [1]. A well-known example is
the compost pile, which is considered a harsh
environment as large numbers of microbes compete for
nutrients, oxygen and space [2]. Various biological char-
acteristics allow A. fumigatus to thrive in this environ-
ment, including rapid and efficient germination,
tolerance for elevated temperatures, and a metabolism
that is responsive to variation in nutrient sources [3, 4].
Furthermore, A. fumigatus propagates via asexual co-
nidia that can be dispersed over wide geographic dis-
tances by air currents, and that can germinate to grow
under a broad range of environmental conditions [5]. To
survive and thrive, Aspergillus needs to rapidly adapt to
these often challenging environments.
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The remarkable ability of A. fumigatus to grow in di-
verse environments, contributes to its role as the pre-
dominant fungal pathogen of immunocompromised
patients. As a result, Aspergillus infections are increas-
ingly recognized as a global health problem. In humans,
several diseases may be caused by A. fumigatus, ranging
from allergic conditions to acute invasive aspergillosis
[5, 6]. Azole antifungals are the primary choice for pre-
vention and treatment of Aspergillus infections. Azoles
inhibit the 14-α demethylase Cyp51A, as they function
as a ligand of the heme group and interact with the pro-
tein structure through the azole drug side chains [7].
The inhibition of Cyp51A results in accumulation of
toxic sterols, destabilisation of the plasma membrane
and subsequent cell death [8]. However, A. fumigatus is
able to adapt to the presence of azoles, which facilitates
persistence of the species and compromises treatment
options in the clinic [9].
Adaptation can be defined as the acquisition of adap-
tive traits through natural selection, which enables the
organism to adjust to life in the prevailing or new envir-
onment [10]. Before natural selection occurs, the organ-
ism quickly adapts to a new environment by exerting its
phenotypic plasticity (PP). PP allows organisms to adjust
their physiology to adapt to a new and challenging envir-
onment, to still be able to maintain growth and
reproduction [11, 12]. These adaptations precede the de-
velopment of genetic changes and the resulting newly
acquired traits. In filamentous fungi, these traits often
arise by spontaneous mutation and subsequent selection
if the new genotype has achieved a higher overall fitness
through its phenotypic traits. Crucially, in A. fumigatus,
this process has led to the development of azole resist-
ance [13–16]. Azole resistant strains have emerged in
patients with aspergilloma or chronic pulmonary asper-
gillosis during azole therapy, but also in for instance
organic-waste that contained azole residues. Azole com-
pounds are widely used for various applications includ-
ing food production, plant protection, and material
preservation [17]. Thus, any environment that contains
azole compounds can result in azole resistance develop-
ment in A. fumigatus, provided that the fungus can
complete its life-cycle [15, 18, 19]. As the dominant
mechanism of resistance (TR34/L98H) is suggested to
have originated in the environment, various studies have
focused on the role of azole use in agriculture in the de-
velopment of azole-resistant isolates [20–22].
Previously, a lot of research focused on elucidating the
genetic basis of azole resistance. The most common
mechanisms of resistance in A. fumigatus are modifica-
tions in the cyp51A gene. Various non-synonymous mu-
tations in this gene have been correlated to azole
resistance [13, 23–25]. These mutations cause structural
changes in the conserved active site, preventing azoles
from binding to the enzyme [23]. It is not well under-
stood how the fungus maintains fitness before these mu-
tations arise, and knowledge of the molecular basis of
this development is needed in order to assess the impact
of this phenomenon.
To understand the development of resistance, we pre-
viously investigated whether genetic substitutions could
be induced during exposure to azoles under laboratory
conditions [9, 26]. Wild type A. fumigatus isolates were
exposed to both medical and environmental azoles, or a
mixture of these compounds. The induction experiments
generally resulted in a resistant phenotype already within
three passages. However, genetic alterations were only
found after at least five passages. In three out of 12
clones of A. fumigatus cultured under itraconazole pres-
sure, cyp51A-substitutions G138C or P216L were de-
tected. These substitutions have been reported in
patients who developed azole-resistant Aspergillus dis-
ease during itraconazole therapy [24, 25].
It is not well understood how the fungus maintains fit-
ness before these mutations arise, and thus current
knowledge suggests that adaptation follows a two-step
process. Firstly, patient- and environmentally acquired
resistance both require an actively reproducing fungus
even when exposed to azole compounds. Therefore, PP
adjusts the physiology of A. fumigatus to maintain
growth and reproduction at least to some extent [27].
Secondly, after these physiological adjustments, the
process of natural selection maintains the mutations
from the gene pool that confer genetic resistance in
the azole-containing environment. Clearly, it is im-
portant to understand the adaptation strategies of A.
fumigatus in relation to azole resistance selection and
the clinical implications thereof for management of
Aspergillus diseases.
The capability of A. fumigatus to adapt in the human
host or in the outside environment is an important fun-
gal property, which contributes to treatment failure and
to the increased numbers of resistant A. fumigatus found
worldwide. Therefore, this report focuses on the role of
PP in the evolution of azole resistance. For A. fumigatus,
this plasticity may involve, for instance, increased efflux
pump activity, the activation of several stress-response
pathways, or altering its lipid metabolism as ergosterol
depletion affects membrane homeostasis [28–31]. How-
ever, research is lacking on the cellular events that take
place in the fungus directly after introduction of an anti-
fungal compound to the environment. Furthermore, it is
not known how the plasticity of the fungal physiology fa-
cilitates the selection of mutations. The early response is
crucial, as the fungus needs to retain its metabolism and
preferably its reproductive capability. In this study, the
differential expression of the A. fumigatus genome was
measured at various time points, directly after addition
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of itraconazole to the medium. The results provided im-
portant details on the initial transcriptional dynamics,
and gave insights into membrane transporter activity,
lipid metabolism, and MAPK cascade proteins, impli-
cated to be involved in the process of phenotypic plasti-
city. These insights will allow us to find leads for
targeted interventions.
Results
We conducted an in vitro assay in which we exposed 24 h
old mycelia of clinical A. fumigatus isolates grown at 37 °
C, to sublethal concentrations of itraconazole which might
permit gradual adaptation of the fungus to the new, stress-
ful environment (Table 1). Strains 130–14, 147–03 and
155–40 were grown with 0.32 μl/mL, 0.15 μl/mL and
0.13 μl/mL respectively, corresponding to the IC50 con-
centrations for each strain which were determined by de-
termining the dose-response curve for each strain
(Additional file 1: Figure S1). Mycelia were then harvested
after 30, 60, 120 or 240min respectively, and relative ex-
pression was compared to the mycelia harvested directly
after 24 h without the addition of itraconazole.
Analysis of differentially expressed genes
A total of 401,706,537 sequence reads were obtained, with
an average unique mapping percentage of 86.5% to the
reference genome Af297 [32] (Additional file 2: Table S1).
This implies that these isolates contain genomic sequences
that are not present in the reference genome and thus
cannot be mapped. Principle component analysis (PCA)
revealed that the highest variation between samples was
observed between the time points and that the replicates
clustered together (Additional file 3: Figure S2). The sam-
ples of isolates 130–14 and 147–03 clustered together.
The greatest amount of variation was found between the
samples measured after 30min and those measured after
240min for isolate 130–14, or those measured after 0min
for isolate 147–03. The samples of isolate 155–40 were
further removed from the other two isolates, although
they show a similar pattern over time which could indicate
a different basal expression level of this isolate. After com-
paring the gene expression between the samples taken
without the addition of itraconazole (t = 0) and the
samples incubated with itraconazole at the different time
points, we identified 3955, 3430, 1207 and 1101 differen-
tially expressed genes (DEGs) from a total of 9840 genes
(Genome inventory, AF293 genome, AspGD, April 12,
2018) after 30, 60, 120 and 240min of incubation with
itraconazole respectively (Fig. 1). A volcano plot for each
time point was created to assess the distribution of the
log2FC values relative to the corrected p-value (Fig. 2).
Verification of RNA-seq data by qRT-PCR
To check the quality of our RNA-seq dataset, we verified
the expression of eight differentially expressed genes
(DEGs) over a range of fold changes by conducting
quantitative real time PCR (qRT-PCR) experiments. Genes
were selected from different categories: up-regulated,
down-regulated or non-regulated. Patterns of the RNA-seq
analysis were highly similar to the patterns obtained from
the qRT-PCR assays, confirming that our sequencing re-
sults were reliable (Additional file 4: Figure S3).
Functional characterization of DEGs
To investigate whether itraconazole-responsive genes
could be functionally categorized, Gene Ontology (GO)
enrichment analysis was performed using the AspGD
Table 1 Three clinical A. fumigatus isolates used for
transcriptomic analysis in this study. The minimum inhibitory
concentration (MIC) was determined for itraconazole (ICZ),
voriconazole (VCZ) and posaconazole (PCZ)
MIC (mg/liter)
Isolate Date of isolation ITZ VCZ PCZ
130–14 25/11/2011 1 1 0.25
147–03 25/03/2013 0.5 1 0.25
155–40 23/10/2013 1 1 0.25
Fig. 1 Graph representing the total numbers of differentially
expressed genes after 30 min (3955 genes), 60 min (3430 genes),
120 min (1207 genes) and 240min (1101 genes)
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GO term finder. After removal of general (e.g. ‘biological
process’, ‘metabolic process’) and redundant categories
with REVIGO [33], the most enriched terms from the
categories Biological Process, Molecular Function and
Cellular Component, were selected respectively. GO
term analysis was performed for both the up-regulated
and down-regulated genes [34] (Fig. 3). In general, after
30 min of incubation with itraconazole, the overall re-
sults showed a large group of enriched categories in the
up-regulated genes and a small group of enriched cat-
egories of down-regulated genes. After 240min, these
numbers were reversed; a large group of enriched cat-
egories in the down-regulated genes and a small group
of enriched categories was found in the up-regulated
genes. Overall, no enriched terms were found in the
up-regulated genes after 120 and 240min.
Of the 30 most enriched GO-terms in the Biological
process category, the terms ‘ribosome biogenesis’, ‘ncRNA
metabolic process’, ‘gene expression’ and ‘RNA processing’
were most significant in the up-regulated genes after 30
min, and in the down-regulated genes after 240min. In
addition, most enriched processes in the up-regulated
genes were related to amino acid metabolism, nucleic acid
metabolism, transcription, translation and general trans-
port of RNA and proteins. The only processes enriched in
the down-regulated genes after 30 and 60min were ‘fatty
acid biosynthetic process’, ‘interspecies interaction between
organisms’ and ‘oxidation-reduction process’. These results
indicate a decreased production of fatty acids during the
first 60min. Furthermore, the enrichment of ‘interspecies
interaction between organisms’ indicates a decreased ex-
pression of genes involved in, for instance, host interaction.
After 240 min, many terms were enriched in the
down-regulated genes, including ‘response to drug’ and
‘response to chemical’, indicating that transcription of
genes that was altered as a response to the addition of
itraconazole, is especially important during the first 2 h
of incubation.
Fig. 2 Volcano plots of the differentially expressed genes at all time points. For each gene, the log2FC value was plotted against its respective
test P-value. The red line running parallel to the x-axis indicates the statistical cutoff (P < 0.05), whereas the red line running parallel to the y-axis
indicates the biological cutoff (log2FC < − 1 or > 1). Note that the y-axis displays a variable –log10(adjusted p-value), as the number of significant
genes decreases over time
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Fig. 3 Heatmap of the most significant GO terms in the categories biological process, molecular function and cellular component. Highly
redundant terms were removed with REVIGO. GO term enrichment was performed for the significant up- and down-regulated genes separately,
for each time point. The colors represent the corrected p-value of each term
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In the category Molecular Function, the term ‘drug
binding’ was enriched in the up-regulated genes after 30
min and enriched in the down-regulated genes after 240
min, indicating the increase of gene products that bind
specifically to a drug during the first 30 min. Further-
more, ‘unfolded protein binding’, was enriched in the
down-regulated genes after 240min. This term mainly
refers to binding unfolded ER proteins, indicating a pos-
sible increase of incorrectly folded proteins that activate
an ER-stress response.
In the Component category, various terms specifically
referred to adjustments to the exterior of the cell. As
itraconazole disturbs ergosterol biosynthesis, it is likely
that membrane integrity is impaired. Interestingly, the
cell adjusts various transcriptional processes related to
the plasma membrane and the fungal cell wall, as a re-
sponse to itraconazole. The GO term ‘plasma mem-
brane’ was the only enriched term after 30 min in the
down-regulated genes. After 60 min, the term ‘cell per-
iphery’ was also enriched in the down-regulated genes,
and the terms ‘hyphal cell wall’ and ‘cell surface’ were
enriched in the down-regulated genes after 240 min.
DEGs during all time points
As the majority of all genes is differentially expressed only
transiently, it would be valuable to assess whether certain
genes would be differentially expressed during the whole
time course, indicating an important role for these genes
in the transcriptional response to itraconazole.
We investigated all genes that were differentially expressed
during all time points, and a core group of 186 genes was
identified (Fig. 4). Down-regulated genes included for in-
stance; the bZIP transcription factor Yap1 (Afu6g09930), the
sensor histidine kinase Fos-1/TcsA (Afu6g10240), the major
allergen Aspf2 (Afu4g09580), and the putative calcineurin
binding protein CbpA (Afu2g13060). Amongst the constant
up-regulated genes were the putative sterol 14α demethylase
Erg6 (Afu4g03630) and the fatty acid oxygenase PpoA
(Afu4g10770).
Furthermore, nine transcription factors, three RING
finger proteins, five heat shock proteins, six MFS trans-
porters and 26 hypothetical proteins with no current
known function were identified.
A complete overview of all differentially expressed
core group genes is shown in Additional file 5: Table S2.
Analysis of the top DEGs
We investigated which individual genes have the highest
changes in gene expression, to assess which genes play an
important role in the physical response to the addition of
itraconazole to the cell. Figure 5 shows a heatmap of the
20 top up-regulated and 20 top down-regulated genes. Of
these 40 genes, 14 genes were annotated as ‘hypothetical
protein’ or ‘conserved hypothetical protein’. The putative
elastase-inhibitor aeiA (Afu3g14940) showed the most
down-regulation after 60min. Furthermore, three putative
transcription factors; ‘fungal specific transcription factor’
Afu3g14600, ‘AflR-like C6 transcription factor’Afu2g15340
and C6 transcription factor Afu4g14590 were strongly
down-regulated after 30 to 60 min. Among the 20
most up-regulated genes, the ‘short-chain dehydrogen-
ase/reductase protein’ Afu3g02120 was the most
up-regulated after 30 min. The two putative RTA1 do-
main proteins Afu3g00920 and Afu3g01030 showed a
strong up-regulation after 30 to 60 min. Interestingly,
nscA (Afu7g00160) and nscD (Afu7g00170) which are
both encoded in the nsc/fcc secondary metabolite
gene cluster, were strongly up-regulated. These genes
are implicated to play a role in neosartoricin and
fumicycline A biosynthesis. Neosartoricin was previ-
ously identified as an immunosuppressive polyketide,
and fumicycline A production was shown to be in-
duced upon exposure to the bacterium Streptomyces
rapamycinicus, although no further functions have
been addressed to this compound [35, 36].
Expression profile of genes encoding putative membrane
transporters
Many studies have emphasized the important role of drug
efflux transporters in drug resistance in various fungal
species. These transporters can be categorized as an
ATP-binding cassette transporter (ABC-transporter) or a
Major Facilitator Superfamily transporter (MFS-transpor-
ter), and play an important role in fungal survival [37–39].
To investigate their role in PP a high-throughput screen is
necessary. We have investigated 75 DEGs involved in or
predicted to be involved in drug efflux and performed hier-
archical clustering based on their expression pattern (Fig. 6).
Amongst the several verified multidrug efflux transporters,
mdr1 (Afu5g06070) and mdr4 (Afu1g12690) were found to
be the most up-regulated during the first 30 to 60min, add-
itionally abcA (Afu2g15130) showed an increased
expression during all time points measured. Other
Fig. 4 Venn diagram showing the overlap between the differentially
expressed genes on each time point. A core set of 186 genes was
differentially expressed during all time points
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up-regulated verified transporters include abcB
(Afu1g10390), abcC (Afu1g14330) and mfs56 (Afu1g05010).
Furthermore, among the other drug-efflux transporters, 25
putative transporters in three different clusters indicated by
a black sidebar, showed a significant up-regulation and a
similar pattern to the known drug-efflux transporters.
These transporters are implicated to play a role in
drug-efflux and should be investigated.
The effect of itraconazole on membrane homeostasis
Azole compounds interfere with ergosterol biosynthesis,
which is suggested to have a significant impact on mem-
brane rigidity [40]. Therefore, we analyzed all genes in-
volved in the ergosterol biosynthesis pathway.
Additionally, we analyzed the key pathways involved in
phospholipid biosynthesis; the CDP-DAG pathway and
the Kennedy pathway, which are postulated to be very
similar to the Saccharomyces cerevisiae pathways [41].
These pathways are involved in the production of
phospholipids from phosphatidic acid de novo, and the
production of phosphatidylethanolamine (PE) and phos-
phatidylcholine (PC) from exogenous ethanolamine and
choline, respectively [42]. Therefore, they play an im-
portant role in maintaining membrane integrity and
DEGs in these pathways could provide leads on how A.
fumigatus exerts its phenotypic plasticity.
Differentially expressed genes in the ergosterol
biosynthesis pathway
To investigate the transcriptional effects of Cyp51A inhib-
ition in the ergosterol biosynthesis pathway, the expres-
sion profile of 30 genes involved in ergosterol biosynthesis
was analyzed, including those in the mevalonate pathway
(Fig. 7a). The mevalonate pathway facilitates the con-
version of acetyl-CoA to farnesylpyrophosphate, the
first compound utilized in the ergosterol biosynthesis
pathway. The erg13A gene showed the highest
down-regulation of log2FC -4.2 after 30 min, while
Fig. 5 Heatmap of the 40 top up-and down-regulated genes. The colors represent the Log2FC of each time point, relative to reference time point t = 0
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Fig. 6 Heatmap showing the hierarchical clustering of the expression patterns of all transporters predicted to play a role in drug-efflux in A. fumigatus.
The colors represent the Log2FC of each time point, relative to reference time point t = 0. Euclidean distances were calculated and complete-linkage
hierarchical clustering was performed. The four bars indicate groups that show moderate to strong up-regulation and could play an important role
in itraconazole-efflux
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the hydroxymethylglutaryl-CoA (HMG-CoA) reduc-
tase hmg1 was the most up-regulated. The other pu-
tative HMG-CoA reductase hmg2 showed a strong
up-regulation, but was not considered significantly
differentially expressed due to an average read count
of 2.53 in the 30 sequenced samples.
In the steroid biosynthesis pathway, an overall
down-regulation of genes within 30 min was observed,
including down-regulation of cyp51A and cyp51B (Fig.
7b). Out of the 20 genes, 15 genes were found to be
down-regulated. The strongest up-regulation at all time
points was measured at the erg6 gene, which functions
directly upstream of Cyp51A and Cyp51B. The other
genes that were measured to be up-regulated, were the
C-8 sterol isomerase gene erg2 and the C-24 sterol re-
ductase erg4.
Phosphatidylethanolamine biosynthetic genes show fast
up-regulation after 30min
Analysis of lipid biosynthetic genes showed mainly
up-regulation of genes involved in the production of one of
the major phospholipids, phosphatidylethanolamine [43]
(Fig. 8). The mitochondrial phosphatidylserine decarboxyl-
ase psd1 was up-regulated log2FC 1.36 after 30min. Fur-
thermore, the genes involved in the production of PE from
extracellular ethanolamine were up-regulated after 30min;
eki1, ect1 and ept1 showed an up-regulation of log2FC 1.49,
1.52 and 2.54, respectively. After 240min, these genes were
down-regulated. The most down-regulated genes included
the C16:0-CoA desaturase ole1 with a log2FC of − 4.16, and
the CDP-diacylglycerol-inositol 3-phosphatidyltransferase
pis1 with a log2FC of − 2.22 after 30min. Down-regulation
of the acyl-CoA desaturase ole1 will decrease the synthesis
of unsaturated fatty acids [44], increasing membrane lipid
saturation. An increase in membrane lipid saturation in-
creases membrane rigidity [45], possibly as a mechanism to
compensate for the loss of rigidity due to ergosterol
depletion.
Differential expression of MAP kinases
Previous research showed that Hsp90 and MAPK pro-
teins are involved in the azole-induced response to
membrane stress in Candida spp. [46]. To investigate
which signaling pathways could be potentially involved
in the physical response to itraconazole, we investigated
the MAPK cascades present in A. fumigatus [31, 47].
Ten genes have been identified as potential compo-
nents of three MAPK cascades in A. fumigatus (Fig. 9)
[31]. The MAPKK Mkk2 (Afu1g05800) is homologous
to S. cerevisiae ScMKK2, and is involved in cell wall in-
tegrity signaling and membrane fluidity sensing [48,
49]. We observed that mkk2 was down-regulated
log2FC of − 1.61 after 60 min. The proteins MAPKKK
SskB (Afu1g10940), MAPKK Pbs2 (Afu1g15950),
A
B
C
Fig. 7 The colors represent the Log2FC of each time point, relative to reference time point t = 0. a Heatmap of all enzymes with a verified or
predicted role in the mevalonate biosynthesis. b Heatmap of all enzymes with a verified or predicted role in the ergosterol biosynthesis. The erg6
gene shows strong up-regulation through the entire time series. c Mevalonate and ergosterol biosynthesis pathways in A. fumigatus
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MAPK SakA (Afu1g12940) and MpkC (Afu5g09100)
have been identified to play a role in high osmolarity
signaling [50, 51], and are considered homologs of the
HOG-MAPK pathway in S. cerevisiae. The sskB gene
was up-regulated log2FC 1.45 after 60 min. The MAPK
proteins SakA and MpkC were up-regulated log2FC
1.26 after 60 min, and up-regulated log2FC 1.33 after
240 min, respectively. Additionally, we found that ho-
mologs of three genes involved in glycerol formation in
A. nidulans were up-regulated [52, 53]. The putative
glycerol-3-phosphate dehydrogenase gfdA (Afu1g02150)
and the putative glycerol-3-phosphate phosphatase
gppA (Afu1g10570) showed up-regulation of log2FC
1.86 and 1.24 after 30 min, respectively. The other puta-
tive glycerol-3-phosphate dehydrogenase gfdB
(Afu2g08250) showed up-regulation of log2FC 1.38
after 60 min (Additional file 6: Table S3).
Comparison with transcriptome data of several stresses
In this study, we have described the general transcrip-
tional patterns at four time points, various categories of
genes and several groups of genes in particular, in the re-
sponse of A. fumigatus to itraconazole. It should be
noted that many transcriptional changes measured are
presumably part of a general stress response which is ac-
tivated not only in response to itraconazole stress. To in-
vestigate this, all differentially expressed genes were
compared with the transcriptome data of previously
conducted research [47, 54]. In the study of Da Silva
Ferreira et al. mycelia were exposed to voriconazole, and
A B
Fig. 8 a Heatmap of all A. fumigatus enzymes homologous to S. cerevisiae enzymes which exert a key function in (phospho)lipid metabolism. The
colors represent the Log2FC of each time point, relative to reference time point t = 0. The genes indicated by a black sidebar are orthologues to
the S. cerevisiae genes responsible for de novo biosynthesis of phosphatidylethanolamine, and show a 1.5–2.4 log2FC. b Glycerolipid biosynthesis
pathways in S. cerevisiae
Fig. 9 Heatmap of all verified and putative MAP kinases in A. fumigatus. The colors represent the Log2FC of each time point, relative to reference
time point t = 0. The MAPK sakA and the MAPKKK sskB show a 1.3 log2FC and a 1.5 log2FC after 60 min, respectively
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analyzed after 30, 60, 120 and 240 min of incubation via
microarray analysis. In the study of Takahashi et al., vari-
ous stress responses were induced through heat shock
(37 °C and 48 °C), osmotic stress, and superoxide stress,
and the transcriptomic changes were monitored through
RNA-seq at 15, 30, 60, 120 and 180 min after induction.
The genes were selected based on the cutoff values
log2FC > 1 or < − 1, and DEGs at all time points were
combined. DEGs from both heat shock treatments were
also combined. A Venn diagram overlapping these genes
was generated, (Fig. 10, Additional file 7: Table S4). A
group of 257 genes was identified uniquely to be
differentially expressed upon exposure to itraconazole
(Additional file 8: Table S5). Of these 257 unique genes,
five genes were merged due to complex annotation
changes. The most up-regulated gene during all time
points with a log2FC 2.7 to 10.7 has predicted oxidore-
ductase activity and a role in metabolic process
(Afu3g02120). The most down-regulated gene after 30
min with a log2FC of − 7.6 has predicted oxidoreductase
activity and a role in an oxidation-reduction process
(Afu4g00560). The most down-regulated gene after 60,
120 and 240min with a log2FC of − 4.1 to − 6.1 has pre-
dicted coenzyme binding and oxidoreductase activity
(Afu5g01250). Several other down-regulated genes in this
group are the O-methyltransferase tpcA (Afu4g14580), the
putative alpha-amylase amyA (Afu3g00900), and the es-
sential 1,3-beta-glucanosyltransferase gel4 (Afu2g05340).
Additionally, the putative C-5 sterol desaturase erg3C
(Afu8g01070), the putative sterol sensing factor insA
(Afu4g07680), and an ortholog of a gene which exhibits in-
termembrane sterol transfer activity in S. cerevisiae
(Afu5g07100), are down-regulated. The up-regulated genes
contain the allergen aspf28 (Afu6g10300), the parvulin-like
peptidyl-prolyl cis-trans isomerase par1 (Afu1g05450), and
the cbkA gene (Afu1g09950) which is regulated by the crzA
transcription factor in A. fumigatus [55].
Discussion
The goal of this study was to investigate differential gene
expression in azole-susceptible clinical strains after the
addition of sub-lethal concentrations of itraconazole, to
gain valuable insights into the way A. fumigatus exerts
its phenotypic plasticity and manages to survive. We
gained insight in the general expression patterns which
take place as A. fumigatus adapts to the presence of an
antifungal compound, and identified 25 potential
drug-efflux transporters which potentially aid the fun-
gus to survive by exporting itraconazole from the cell.
Furthermore, we demonstrated that the erg6 gene was
up-regulated during the whole time course and that the
genes facilitating PE production from extracellular eth-
anolamine were up-regulated, indicating an increased
production of this phospholipid. Finally, we observed
an increased expression of several MAPK cascade pro-
teins which are also involved in HOG signaling. This
study is, to our knowledge, the first study to use
RNA-seq to measure gene expression of clinical isolates
in response to itraconazole.
In our experimental setup, we compared the isolates
of each time point with the isolates directly harvested
after 24 h. Although we do not distinguish between the
transcriptional changes caused by itraconazole or other
changes related to mycelial growth progression, previous
research demonstrated that A. fumigatus resides in the
exponential growth phase after 24 h, in various nutrient
media [56]. Interpreting transcriptomics results is lim-
ited by the fact that only 487 (4.95%) genes have been
experimentally verified and characterized in A. fumiga-
tus, making the interpretation of transcriptomics results
challenging (Aspergillus fumigatus Af293 Genome Snap-
shot, AspGD, May 14th, 2018). Although many gene
functions are predicted computationally through known
functions of homologous genes in other closely related
species, they are yet to be experimentally confirmed. It
was notable that the number of enriched GO terms per
time point was not a direct consequence of the number
of genes in the group; the 2254 down-regulated genes
after 30 min yielded only five enriched GO terms in the
category process, as opposed to the 1701 up-regulated
genes after 30 min, which yielded a total of 194 enriched
GO terms in the category process before the removal of
redundant terms. This suggests that many cellular pro-
cesses are down-regulated after 30 min, but all to similar
extent as no specific terms are enriched.
GO term enrichment analysis showed increased activ-
ity of various specific processes related to the exterior of
Fig. 10 Itraconazole responsive genes. Venn diagram comparing all
DEGs of this study and the DEGs found by da Silva Ferreira et al.,
and Takahashi et al., after exposing A. fumigatus to different stresses
to compare transcriptional responses. After removal of merged
genes, 251 unique DEGs remain which were only differentially
expressed upon exposure to itraconazole
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the cell, consistent with previous research that states
that itraconazole decreases membrane integrity by inter-
fering with ergosterol biosynthesis [40, 57]. The cellular
component category also showed the enriched term
‘extracellular matrix’ in the up-regulated genes after 60
min, which mainly comprises of genes which are part of
the fungal biofilm matrix. These biofilms are often in-
volved in host adherence and provide protection from
extracellular stresses, suggesting an important role for
biofilm formation in the physiological response of A.
fumigatus [58, 59].
The involvement of elastase in fungal virulence is dis-
cussed in several studies, and its contribution to patho-
genicity, by breaking down elastin in lung tissue, is not
well established for A. fumigatus [60–63]. We found that
the putative elastase inhibitor aeiA (Afu3g14940) was
the most down-regulated gene in our dataset (log2FC
8.27). There is a possibility that these clinical strains
have specifically adapted to the lung environment, and
that there are other beneficial effects that do not influ-
ence virulence, although these results suggest that A.
fumigatus greatly adjusts its elastase activity upon itraco-
nazole stress.
Amongst the strongest up-regulated genes were two pu-
tative RTA1 domain proteins. Not much is known about
this gene family, that was initially found to be involved in
the export of long sphingoid bases in S. cerevisiae [64].
Interestingly, overexpression of ScRTA1 results in
7-aminocholesterol resistance, an antifungal compound
that inhibits sterol biosynthesis. Heme-deficiency was also
shown to induce ScRTA1 expression. It is likely that dis-
turbance of ergosterol biosynthesis influences iron
homeostasis in the fungal cell, as these processes share
mevalonate as a precursor and are both regulated by the
sterol regulatory element binding protein SrbA [65, 66].
When heme or iron sources are deficient, siderophore me-
diated iron-uptake is increased, and hmg1 expression is
up-regulated. This is consistent with our finding that
hmg1 expression is increased [64, 66]. The role of RTA1
proteins in the physical response to azoles has not yet
been established and could provide an interesting lead.
A large number of transporters have been described in
A. fumigatus, and the fungus can defend itself against a
large number of toxic compounds via for instance
drug-efflux pump activity [67, 68]. The genome of A.
fumigatus is predicted to contain at least 49 ATP binding
cassette (ABC) family transporter genes and 278 major fa-
cilitator superfamily (MFS) genes. From the AspGD web-
site, only genes encoding transporters were extracted that
were predicted to play a role in drug efflux specifically.
This might leave out potential other transporter genes,
which are not yet computationally predicted to be in-
volved in drug efflux in general. Nevertheless, 25 trans-
porters showed comparable expression patterns to the
verified drug-efflux transporters within the first. These
transporters could play an important role in physical re-
silience induced by PP, and their involvement should be
addressed experimentally in future research.
We investigated to what extent itraconazole influences
the expression of ergosterol biosynthetic genes. Alter-
ations in the ergosterol biosynthesis pathway have been
shown to confer resistance in a previous study with
Candida albicans [69]. Strikingly, erg6 showed a signifi-
cant up-regulation of log2FC 1.78–3.54 during the whole
time course, as opposed to the rest of the ergosterol bio-
synthetic pathway, which showed a general
down-regulation, or no-regulation. Recent studies sug-
gested that not Cyp51A, but Erg6 is the 14α-lanosterol
demethylase in A. fumigatus, as opposed to S. cerevisiae,
where ScERG6 encodes a sterol 24-C-methyltransferase
further downstream [8, 70–72]. Erg6 functions directly
upstream of Cyp51A, where it first converts lanosterol to
eburicol. Inhibition of Cyp51A by azoles and up-regula-
tion of erg6 would then lead to a strong accumulation of
eburicol. Why the increased production of eburicol would
be a favorable trait when this compound possibly already
accumulates as the Cyp51A enzyme is inhibited by
azoles [8], is not clear. It is possible that a feedback
regulation mechanism senses the absence of the
Cyp51A/B product, 4,4,24-trimethylcholesta-8,24(28)--
dien-3β-ol, when they are inhibited by azoles with the in-
creased production of their substrate as a direct result.
The genes involved in biosynthesis of phosphatidyleth-
anolamine (PE) from extracellular ethanolamine showed
a predominant up-regulation. A recent study on mam-
malian cells suggests that PE is the key phospholipid in
maintaining proper membrane rigidity, and they found
that a decrease in cholesterol resulted in a strong in-
crease of PE relative to the other phospholipids [73].
These genes were identified as the most up-regulated of
all lipid biosynthesis genes investigated in this study and
could imply an increase of PE in the membranes to
maintain proper rigidity, when ergosterol levels are de-
pleted [45, 74].
The important role of cell signaling in fungal adapta-
tion to stress factors and antifungals has been exten-
sively demonstrated [31, 75–77]. We have investigated
the involvement of MAPK cascade proteins upon azole
stress. The mpkB gene is still uncharacterized in A. fumi-
gatus, however, the mpkB gene in A. nidulans and the
FUS3 gene in S. cerevisiae are well-described homologs.
Their role in the cellular pheromone response and
sexual development is established [78, 79], indicating a
possible role of these processes in the response to itraco-
nazole stress. Furthermore, we measured a significant
up-regulation in the sakA MAPK gene, which is hom-
ologous to the HOG1 gene of S. cerevisiae. This gene is
the key MAP kinase involved in the regulatory processes
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in response to osmotic, oxidative, heat, and hypoxia me-
diated stresses [31]. In A. fumigatus, sakA has been
shown to play an important role in the osmotic and oxi-
dative stress responses. Deletion mutants showed an in-
creased sensitivity to itraconazole and amphotericin B
[80], which is consistent with our finding that sakA ex-
pression is increased as a response of A. fumigatus to
itraconazole. Our results suggest that upon exposure to
itraconazole, A. fumigatus differentially regulates genes
which are related to the osmotic stress response and in-
creases its glycerol production. This is supported by our
findings that at least three genes involved in glycerol for-
mation were up-regulated within 60min. Transcriptional
changes of MAP kinases could give insight into the
stress-response mechanisms [47], although MAP kinases
are activated by phosphorylation [81]. Therefore, analysis
of the phosphoproteome could provide additional in-
sights into their direct involvement in adaptation to itra-
conazole stress.
Recently, the mitochondrial complex I has been impli-
cated to play a role in azole resistance. Interestingly, our
results show only a slight down-regulation of the 29.9 KD
subunit of mitochondrial complex I (Afu2g10600: Log2FC
-0.81, P-value 0.01, adjusted P-value 0.07) (Additional file
7: Table S4) after 240min, although deletion of this gene
leads to partial azole resistance (80). The authors suggest
a resistance mechanism based on restoring an unbalanced
oxidative stress response when itraconazole (1mg/L) is
added to the medium. However, the DEGs in our dataset
do not indicate an oxidative response in our isolates
exposed to itraconazole, as we did not measure
up-regulation of genes that are induced upon hypoxic
conditions [82]. Therefore, a down-regulation of the 29.9
KD subunit would not be necessary to rebalance the oxi-
dative stress response. It is also possible that this gene is
not differentially regulated and does not contribute to PP
to gain azole resilience, although further research is neces-
sary to elucidate if higher concentrations of itraconazole
could result in a different expression pattern.
Many mechanisms that cope with cell stress respond
to various stressful conditions, and are not limited to a
specific stress condition or a specific antifungal
compound [47, 83, 84]. To investigate if A. fumigatus
differentially expresses genes solely in response to itra-
conazole, we compared our results to the transcripto-
mics data of previously conducted studies [47, 54]. We
found that 251 genes were differentially regulated spe-
cifically in response to itraconazole. Although genetic
and physiological differences between isolates com-
pared across different studies may influence this out-
come, these results suggest that transcription of these
genes is specifically altered as a response to itracona-
zole stress. Amongst these genes is the down-regulated
insA (Afu4g07680) gene, which is a putative sterol
sensing factor. The mammalian homolog encodes an
ER-anchored protein which prevents the transcriptional
activation of genes involved in the synthesis and uptake
of cholesterol, by binding to sterol regulatory element
binding proteins (SREBPs) [85]. It is possible that A.
fumigatus anticipates on ergosterol deficiency by
down-regulating this gene to prevent inhibition of
sterol synthesis and uptake, although little is known
about the sterol sensing mechanisms in A. fumigatus.
Remarkably, previous reported DEGs resulting from
voriconazole treatment share but 72,6% with DEGs from
our study, despite of their shared mechanism of action.
These difference could be appointed to the treatment of
the isolates with a higher concentration of voriconazole
(0.5 μg/mL) and although the exact MIC of the tested
isolates was not documented, this could explain the dif-
ferent DEGs found. Additionally, the isolates tested in
this study demonstrated that even between different iso-
lates that have the same MIC, the basal expression of
the transcriptome can differ. Furthermore, the difference
could be appointed to the comparison of microarray re-
sults with RNA-seq results, with the latter having higher
resolution. Future studies could be improved by intro-
duction of a conserved laboratory strain in every experi-
ment, which would facilitate better comparison.
As demonstrated in this study, RNA-seq is a promis-
ing method to provide better insight in the physiological
changes and cellular defense mechanisms [86–88].
Although many processes can be monitored this way, it
should be taken into account that a decreased or in-
creased transcription, does not necessarily lead to an in-
creased translation. Additionally, post-translational
processes could further impact on the suggested in-
creased abundance of activated proteins. It is essential
that potential genes or pathways involved in the cellular
response to itraconazole are confirmed by the generation
of gene-deletion mutants. Furthermore, it could be
promising to look at the direct consequences of the vari-
ous transcriptional changes related to ergosterol and
lipid biosynthesis, by investigating the full lipidome of A.
fumigatus mycelia under various conditions.
Conclusions
Our data strongly suggests that phenotypic plasticity allows
A. fumigatus to substantially adapt its transcriptome within
60min of exposure to itraconazole, after which the cells pro-
posedly reach an improved homeostatic state. We showed
that short-term adaptation through PP includes immediate
up-regulation of several drug-efflux membrane transporters,
activation of signaling cascades, and various alterations in
gene expression in the ergosterol biosynthesis and phospho-
lipid biosynthetic processes. Thus, our study supports the
notion that transcriptomic analyses by RNA-seq can give
major insights in the differentially expressed genes, enabling
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us to understand how the direct response of A. fumigatus to
itraconazole promotes survival of the fungus in the patient
and in the outside environment before any stable genetic
mutations arise. Further research on PP and the short-term
adaptation processes of A. fumigatus can improve the un-
derstanding on how the fungus survives during azole expos-
ure. Increasing this fundamental knowledge is crucial in
managing the spread of azole resistant A. fumigatus isolates
and developing future antifungal therapies.
Methods
Isolates, media and culture conditions
Isolates were used with an MIC of 0.5 or 1 for itracona-
zole and the same MIC for voriconazole and posacona-
zole respectively, to exclude the possibility that great
differences in outcome could be assigned to the differ-
ences in MICs for these isolates. The isolates were se-
lected from three different patients from separate
hospitals in the Netherlands. All isolates are listed in
Table 1. Isolates were cultured on either Sabouraud Dex-
trose Agar (SDA) (Oxoid) (1% peptone, 4% glucose, 1.5%
agar, pH 5.6) or Aspergillus Minimal Medium (AMM) as
described in the supplemental material of reference [89]
containing per liter: 10 g glucose, 5.95 g NaNO3, 0.522 g
KCl, 1.5 g KH2PO4, 50 mg MgSO4·7H2O, 1 mL trace ele-
ments). Trace elements contained (per 200 mL): 10 g
EDTA, 4.4 g ZnSO4·7H2O, 1.01 g MnCl2·4H2O, 0.315 g
CuSO4·5H2O, 0.22 g (NH4)6Mo7O24·4H2O, 1.0 g Fe(II)-
SO4·7H2O, and 2.2 g H3BO3 [90]. All compounds were
produced by Merck (Darmstadt, Germany). Isolates were
stored in 20% glycerol at − 80 °C, and subcultured on
SDA at 37 °C for 4–5 days. Conidia were harvested with
a wet cotton swab and resuspended in Milli-Q contain-
ing 0.1% Tween 20. Approximately 2,6 × 105 CFU/mL of
conidia were used to inoculate 5 mL of AMM in 15mL
tubes. Conidia were inoculated in duplicate. After 24 h
of growth at 37 °C while rotating, itraconazole (Sigma)
was added at IC50 to each tube except the T = 0 tubes,
which were immediately harvested through Miracloth
(Merck). Remaining mycelia were harvested through
Miracloth after 30, 60, 120 and 240min. Harvested my-
celia were directly frozen in liquid nitrogen.
Dose-response curves
For determining the itraconazole concentration where
growth is estimated to be 50% (IC50), dose-response
curves were made by growing each strain (n = 5) in a
96-wells plate containing AMM with itraconazole con-
centrations ranging from 0.016 μg/mL to 8 μg/mL. Plates
were kept at 37 °C in a microtiter plate reader (Anthos
Labtec Instruments GmbH, Salzburg, Austria) for 48 h,
and optical density (OD) was measured every hour at
405 nm. After subtraction of the ODs of the empty wells,
the percentage of growth from the ODs of the
inoculated wells for each well was correlated with the
relative OD estimated by the following equation: (OD405
of wells that contained itraconazole/OD405 of the itraco-
nazole-free well) × 100. The relationship was determined
by a non-linear regression analysis and the Hill equation
with a variable slope fitted to the data. Goodness of fit
was checked by the r2 values. All analyses were per-
formed by using GraphPad Prism, version 6.0, for OS X
(GraphPad Software, San Diego, USA).
RNA sequencing
After harvesting, mycelia were lysed by bead-bashing
using a MagNa Lyser instrument, three times for 30 s at
7000 rpm (Roche, Basel, Switzerland). RNA was extracted
using TRIzol reagent (Invitrogen, Breda, the Netherlands).
Pellets were resuspended in 100 μL DEPC treated water.
RNA integrity was verified by agarose gel electrophoresis.
Total RNA was stained with Midori Green (Nippon Gen-
etics, Dueren, Germany) and visualized with UV light.
Purity of all samples (A260/A280 ≥ 1.5 and A260/A230 ≥ 2.0)
was determined using a NanoDrop 1000 (Thermo Scien-
tific, MA, US). Pooled cDNA libraries were constructed
with the TruSeq RNA Sample Prep Kit v2 (Illumina, San
Diego, USA) according to manufacturer instructions.
Quality of the libraries was verified with an Agilent 4200
Tapestation System (Agilent Technologies). Paired-end
reads of 2 × 75 bp were generated in High Output mode
on a NextSeq 500 sequencer (Illumina, San Diego, USA).
Identification of differentially expressed genes
Reads were aligned with STAR v2.5.3A [91] against the
reference genome sequence of A. fumigatus Ensemble
CADRE 30 downloaded from EnsemblFungi. Differentially
expressed genes (DEGs) were identified by DESeq2 for R
by Bioconductor (BaseMean ≥30, P-value < 0.05, adjusted
P-value < 0.1, log2FC > 1 or < − 1), and results were cor-
rected for multiple testing by the Benjamini-Hochberg
principle [92].
GO analysis
Functional categories of DEGs were grouped according
to the Gene Ontology (GO) term, using the GO Term
Finder on the AspGD website to identify significant
terms (p ≤ 0.05) [93]. The False Discovery Rate cutoff
value was set to p ≤ 0.05. REVIGO was used to remove
redundant GO terms [33] and allowed similarity was set
to 0.5. Terms with over 30% frequency were removed to
avoid general terms. Up-regulated and Down-regulated
genes were screened separately for enriched categories,
to improve statistical power [34].
Validation of RNA-seq results by quantitative real-time PCR
All primers are listed in Additional file 9: Table S6. Eight
genes with different expression patterns were selected,
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and expression was confirmed in all three strains separ-
ately. RNA isolation and cDNA synthesis were per-
formed as described above. Quantitative real-time PCR
was performed with gene-specific primers, using the
actin gene (act1) as reference gene. PCR was performed
using Roche Lightcycler 480 SYBR Green I Master ac-
cording to the protocol of the manufacturer. PCR condi-
tions were as follows: Denaturation at 95 °C for 5 min,
followed by 45 cycles of denaturation at 95 °C for 10 s,
primer annealing at 60 °C for 10 s, and extension at 72 °C
for 10 s. Expression levels were calculated by the
ΔΔCT-method, and normalized for actin mRNA expres-
sion levels [94]. All qRT-PCR experiments were
per-formed at least in duplicates.
Statistical analysis and figure construction
Heatmaps and volcano plots were generated by Rstudio
Version 1.0.143 for OS X. For generating heatmaps, gplots
v3.0.1 was used. For generating volcano plots, ggplot2
V2.2.1 was used. Exported images were assembled with
Adobe Illustrator CC 2015. Venn diagrams were created
with Biovenn (http://www.biovenn.nl/index.php) and the
Venn tool by (http://bioinformatics.psb.ugent.be/webt
ools/Venn). Graphs of qRT-PCR and dose-response curve
analyses were generated by using GraphPad Prism, version
6.0, for OS X (GraphPad Software, San Diego, USA). Error
bars represent standard error of the mean.
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